WebWe would like to show you a description here but the site won’t allow us. WebJan 27, 2024 · CellProthera, une start-up française de biotechnologie, a présenté vendredi les premiers résultats de l’étude clinique de phase II concernant sa thérapie de régénération du muscle ...

Alsace : Amaelles déploie ses services de e-santé auprès des seniors

WebApr 3, 2024 · Mulhouse biotech Cellprothera, specializing in cell regeneration, has just raised 4.4 million euros. With this sum, the biotech intends to accelerate its development, … WebSep 1, 2009 · CellProthera is a biotechnology company making regenerative medicines using stem cells that is headquartered in Mulhouse, France and was founded in 2008 by Philippe Henon. Funding . Seed . On September 1, 2009 CellProthera completed their seed funding round with €100 thousand in funding from Alsace Business Angels. how to sell dvds to amazon

CellProthera Pipeline

WebJan 30, 2010 · CellProthera is a leading medical biotechnology company located in Mulhouse, in eastern France, specialized in the development of autologous cell therapy for the regeneration of cardiac tissue after myocardial infarction. This treatment consists in the automated production of a graft of adult stem cells collected in the patient’s own blood ... WebCellProthera is the first company having conducted successful proof of principle study with autologous CD34+ stem cells to repair myocardial tissue after acute myocardial infarct … WebRefractory angina (RFA) is chronic chest pain due to furring up of the blood supply to the heart that causes unbearable symptoms and poor quality of life despite current medical treatment, angioplasty, or bypass surgery. New cases are estimated at 75 000 in the US, 30 000- 50 000 in Europe and just under 20 000 in the UK. These patients pose ... how to sell electricity to power company